Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 26, 2010Annual Review of Medicine

Mechanisms of Endocrine Resistance in Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

COC. Kent OsborneAstraZeneca (United Kingdom)RSRachel SchiffBaylor College of Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Osborne et al. (2010) studied this question.

synapsesocial.com/papers/69df6ecade200760a86151b4https://doi.org/10.1146/annurev-med-070909-182917
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer.1994 · 397 citations
  2. 2Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site2000 · 87 citations
  3. 3Regulation of Estrogen Receptor Nuclear Export by Ligand-Induced and p38-Mediated Receptor Phosphorylation2002 · 201 citations
  4. 4Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-982007 · 912 citations
  5. 5Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase2005 · 494 citations